These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3472705)

  • 1. Antimicrobial activity of imipenem and SCH34343 against Legionella species.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1987 Apr; 6(4):307-9. PubMed ID: 3472705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of imipenem on Legionella pneumophila, with a note on the treatment of two cases.
    Farrell ID; Barker J; Chiodini PL; Hutchison JG; Geddes AM
    J Antimicrob Chemother; 1985 Jul; 16(1):61-5. PubMed ID: 3862660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Legionella spp. to imipenem and 27 other beta-lactam antibiotics.
    Ruckdeschel G; Ehret W; Ahl A
    Eur J Clin Microbiol; 1984 Oct; 3(5):463-7. PubMed ID: 6594234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of DNA probes to antimicrobial susceptibility testing of Legionella pneumophila.
    Reznicek M; Bale M; Pfaller M
    Diagn Microbiol Infect Dis; 1991; 14(1):7-10. PubMed ID: 2013212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Legionella species to antimicrobial agents.
    Chen SC; Paul ML; Gilbert GL
    Pathology; 1993 Apr; 25(2):180-3. PubMed ID: 8367199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
    Dubois J; St-Pierre C
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):261-5. PubMed ID: 10212753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime.
    Bauernfeind A
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():155-64. PubMed ID: 3897170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions.
    Liebers DM; Baltch AL; Smith RP; Hammer MC; Conroy JV
    J Antimicrob Chemother; 1989 Jan; 23(1):37-41. PubMed ID: 2526110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of single and combined antibiotics on the growth of Legionella pneumophila using time-kill studies.
    Barker JE; Farrell ID
    J Antimicrob Chemother; 1990 Jul; 26(1):45-53. PubMed ID: 2211446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents.
    Vildé JL; Dournon E; Rajagopalan P
    Antimicrob Agents Chemother; 1986 Nov; 30(5):743-8. PubMed ID: 3492176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of lomefloxacin (SC 47111 or NY-198) against isolates of Legionella spp.
    Dubois J; Joly JR
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):89S-91S. PubMed ID: 2791504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro activity of sulphones alone and in combination with ampicillin or amoxicillin against Legionella pneumophila and other Legionella spp. including beta-lactamase studies.
    Jones RN; Thornsberry C; Wilson HW; McDougal LK
    Diagn Microbiol Infect Dis; 1985 Mar; 3(2):179-83. PubMed ID: 3872195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of Ro 23-9424 against clinical isolates of Legionella species.
    Edelstein PH; Edelstein MA
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2559-61. PubMed ID: 1489206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results.
    Ruckdeschel G; Dalhoff A
    J Antimicrob Chemother; 1999 May; 43 Suppl B():25-9. PubMed ID: 10382872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the Etest to antimicrobial susceptibility testing of Legionella spp.
    Rhomberg PR; Bale MJ; Jones RN
    Diagn Microbiol Infect Dis; 1994 Jul; 19(3):175-8. PubMed ID: 7820999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae.
    Pikis A; Donkersloot JA; Akram S; Keith JM; Campos JM; Rodriguez WJ
    J Antimicrob Chemother; 1997 Jul; 40(1):105-8. PubMed ID: 9249211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity of antibiotics against Legionella micdadei (Pittsburgh pneumonia agent).
    Dowling JN; Weyant RS; Pasculle AW
    Antimicrob Agents Chemother; 1982 Aug; 22(2):272-6. PubMed ID: 6927637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter species.
    Chin NX; Neu HC
    Chemotherapy; 1987; 33(3):183-8. PubMed ID: 3109815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibiotic susceptibility of Legionellaceae: search for alternative antimicrobial drugs.
    Traub WH; Spohr M
    Chemotherapy; 1984; 30(3):182-7. PubMed ID: 6734305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Ishag AJ; Durgham SM; Shibl AM
    Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.